FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387068008: Terazosin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461246017 Terazosin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481182010 Terazosin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
376371000195119 terazosina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844311000172112 térazosine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin (substance) Is a Alpha-1 adrenergic receptor antagonist true Inferred relationship Some
Terazosin (substance) Is a allergène médicamenteux false Inferred relationship Some
Terazosin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha-1 adrenergic receptor antagonist (disposition) true Inferred relationship Some
Terazosin (substance) Is a Alpha adrenergic receptor antagonist false Inferred relationship Some
Terazosin (substance) Is a Vasodilator (substance) true Inferred relationship Some
Terazosin (substance) Is a Autonomic agent (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing terazosin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Terazosin (substance) Inferred relationship Some 1
Terazosin adverse reaction Causative agent (attribute) True Terazosin (substance) Inferred relationship Some 1
Allergy to terazosin (finding) Causative agent (attribute) False Terazosin (substance) Inferred relationship Some
Terazosin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin (as terazosin hydrochloride) 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin (as terazosin hydrochloride) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin 1mg+2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin (as terazosin hydrochloride) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin hydrochloride [see chap B for generic preps] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin 1mg tablet and 2mg tablet and 5mg tablet starter pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin hydrochloride 2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin hydrochloride 5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin hydrochloride 10mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Terazosin hydrochloride Is a False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some
Allergy to terazosin (finding) Causative agent (attribute) True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Terazosin (substance) Inferred relationship Some 1
Terazosin hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Terazosin (substance) Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Terazosin (substance) Inferred relationship Some 1
Terazosin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Terazosin (substance) Inferred relationship Some 1
Product containing only terazosin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Terazosin (substance) Inferred relationship Some 1
Terazosin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 1 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 1 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 5 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 10 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Terazosin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start